Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics ® will be presented at the 18th ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results